Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Johnson

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
Friedreich ataxiaW G Johnson
Neurology|May 1, 1991
Genetic susceptibility to Parkinson's diseaseW G Johnson
Neurology|November 1, 1981
The clinical spectrum of hexosaminidase deficiency diseasesW G Johnson
Pharmacoeconomics|September 4, 1997
The costs of epilepsy and cost-based evaluations of anticonvulsantsW G Johnson
Annals of the New York Academy of Sciences|January 1, 1981
Compensation for occupational illnessW G Johnson
Archives of Neurology|August 6, 2000
Two expanded repeats in the same patient: An effect on phenotype?W G Johnson
Seminars in Neurology|December 1, 1993
Motor neuron diseases resulting from hexosaminidase deficiencyW G Johnson
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1983
Genetic heterogeneity of the hexosaminidase deficiency diseasesW G Johnson
American Journal of Medical Genetics|July 14, 1999
DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disordersW G Johnson
Geriatrics|August 1, 1991
Genetic susceptibility to Parkinson's diseaseW G Johnson
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
Friedreich ataxiaW G Johnson
Neurology|May 1, 1991
Genetic susceptibility to Parkinson's diseaseW G Johnson
Neurology|November 1, 1981
The clinical spectrum of hexosaminidase deficiency diseasesW G Johnson
Pharmacoeconomics|September 4, 1997
The costs of epilepsy and cost-based evaluations of anticonvulsantsW G Johnson
Annals of the New York Academy of Sciences|January 1, 1981
Compensation for occupational illnessW G Johnson
Archives of Neurology|August 6, 2000
Two expanded repeats in the same patient: An effect on phenotype?W G Johnson
Seminars in Neurology|December 1, 1993
Motor neuron diseases resulting from hexosaminidase deficiencyW G Johnson
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1983
Genetic heterogeneity of the hexosaminidase deficiency diseasesW G Johnson
American Journal of Medical Genetics|July 14, 1999
DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disordersW G Johnson
Geriatrics|August 1, 1991
Genetic susceptibility to Parkinson's diseaseW G Johnson
Pageof 14